Shanghai Pharmaceuticals Holding Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 4.21%

Shanghai Pharmaceuticals Holding Co Ltd (601607) has an Asset Resilience Ratio of 4.21% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 601607 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥9.90 Billion

≈ $1.45 Billion USD Cash + Short-term Investments

Total Assets

CN¥235.37 Billion

≈ $34.44 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1999–2025)

This chart shows how Shanghai Pharmaceuticals Holding Co Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of Shanghai Pharmaceuticals Holding Co Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Pharmaceuticals Holding Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shanghai Pharmaceuticals Holding Co Ltd (601607) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥9.90 Billion	4.21%
Total Liquid Assets	CN¥9.90 Billion	4.21%

Asset Resilience Insights

Limited Liquidity: Shanghai Pharmaceuticals Holding Co Ltd maintains only 4.21% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shanghai Pharmaceuticals Holding Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shanghai Pharmaceuticals Holding Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
China National Medicines Corp Ltd SHG:600511	Medical Distribution	0.04%
Sigma Healthcare Ltd AU:SIG	Medical Distribution	0.03%
Ebos Group Ltd AU:EBO	Medical Distribution	0.00%
Paragon Care Ltd AU:PGC	Medical Distribution	0.00%
Mayne Pharma Group Ltd AU:MYX	Medical Distribution	4.00%
Cyclopharm Ltd AU:CYC	Medical Distribution	1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A SA:PFRM3	Medical Distribution	4.48%
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd SHG:600332	Medical Distribution	0.00%

Annual Asset Resilience Ratio for Shanghai Pharmaceuticals Holding Co Ltd (1999–2025)

The table below shows the annual Asset Resilience Ratio data for Shanghai Pharmaceuticals Holding Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	4.44%	CN¥10.36 Billion ≈ $1.52 Billion	CN¥233.15 Billion ≈ $34.12 Billion	+0.54pp
2024-12-31	3.90%	CN¥8.63 Billion ≈ $1.26 Billion	CN¥221.21 Billion ≈ $32.37 Billion	-0.89pp
2023-12-31	4.79%	CN¥10.15 Billion ≈ $1.49 Billion	CN¥211.97 Billion ≈ $31.02 Billion	-0.06pp
2022-12-31	4.85%	CN¥9.61 Billion ≈ $1.41 Billion	CN¥198.13 Billion ≈ $28.99 Billion	+4.85pp
2017-12-31	0.00%	CN¥642.58K ≈ $94.03K	CN¥94.34 Billion ≈ $13.81 Billion	0.00pp
2016-12-31	0.00%	CN¥4.06 Million ≈ $594.15K	CN¥82.74 Billion ≈ $12.11 Billion	+0.00pp
2015-12-31	0.00%	CN¥820.23K ≈ $120.03K	CN¥74.34 Billion ≈ $10.88 Billion	+0.00pp
2014-12-31	0.00%	CN¥505.66K ≈ $73.99K	CN¥64.34 Billion ≈ $9.42 Billion	+0.00pp
2013-12-31	0.00%	CN¥339.99K ≈ $49.75K	CN¥56.31 Billion ≈ $8.24 Billion	-0.01pp
2012-12-31	0.01%	CN¥2.92 Million ≈ $427.36K	CN¥51.07 Billion ≈ $7.47 Billion	+0.00pp
2011-12-31	0.01%	CN¥2.66 Million ≈ $389.06K	CN¥47.67 Billion ≈ $6.98 Billion	-0.01pp
2010-12-31	0.01%	CN¥3.23 Million ≈ $473.27K	CN¥28.17 Billion ≈ $4.12 Billion	-0.07pp
2009-12-31	0.08%	CN¥7.29 Million ≈ $1.07 Million	CN¥8.66 Billion ≈ $1.27 Billion	-0.03pp
2008-12-31	0.12%	CN¥9.16 Million ≈ $1.34 Million	CN¥7.76 Billion ≈ $1.13 Billion	-0.38pp
2007-12-31	0.50%	CN¥35.83 Million ≈ $5.24 Million	CN¥7.13 Billion ≈ $1.04 Billion	-0.43pp
2006-12-31	0.94%	CN¥62.50 Million ≈ $9.15 Million	CN¥6.68 Billion ≈ $977.29 Million	-0.88pp
2005-12-31	1.82%	CN¥115.90 Million ≈ $16.96 Million	CN¥6.38 Billion ≈ $933.02 Million	+0.39pp
2004-12-31	1.43%	CN¥92.27 Million ≈ $13.50 Million	CN¥6.46 Billion ≈ $945.91 Million	+0.73pp
2003-12-31	0.70%	CN¥43.13 Million ≈ $6.31 Million	CN¥6.15 Billion ≈ $900.65 Million	+0.64pp
2002-12-31	0.06%	CN¥3.11 Million ≈ $455.01K	CN¥5.40 Billion ≈ $790.60 Million	-1.12pp
2001-12-31	1.18%	CN¥50.57 Million ≈ $7.40 Million	CN¥4.29 Billion ≈ $628.22 Million	-1.65pp
2000-12-31	2.83%	CN¥100.00 Million ≈ $14.63 Million	CN¥3.54 Billion ≈ $517.32 Million	+2.81pp
1999-12-31	0.02%	CN¥695.20K ≈ $101.73K	CN¥3.06 Billion ≈ $447.14 Million	--

pp = percentage points

About Shanghai Pharmaceuticals Holding Co Ltd

SHG:601607 China Medical Distribution

Market Cap

$6.65 Billion

CN¥45.47 Billion CNY

Market Cap Rank

#2977 Global

#398 in China

Share Price

CN¥16.30

Change (1 day)

-1.21%

52-Week Range

CN¥16.18 - CN¥19.48

All Time High

CN¥25.03